CREDIT SUISSE FIRST BOSTON EQUITY PARTNERS (BERMUDA), L.P.

Historique de performance de CREDIT SUISSE FIRST BOSTON EQUITY PARTNERS (BERMUDA), L.P.

Historique insuffisant pour un historique de performance statistique (moins de 5 achats sur le marché).

Historique des transactions de CREDIT SUISSE FIRST BOSTON EQUITY PARTNERS (BERMUDA), L.P.

Co-initiés de CREDIT SUISSE FIRST BOSTON EQUITY PARTNERS (BERMUDA), L.P.

• AUKEN WENDELL G VAN IIICYTOKINETICS INC +1
• CREDIT SUISSE/CYTOKINETICS INC +1
• CREDIT SUISSE FIRST BOSTON ADVISORY PARTNERS, LLCCYTOKINETICS INC +1
• CREDIT SUISSE FIRST BOSTON (BERMUDA) LTDCYTOKINETICS INC +1
• CREDIT SUISSE FIRST BOSTON EQUITY PARTNERS, L.P.CYTOKINETICS INC +1
• CREDIT SUISSE FIRST BOSTON U.S. EXECUTIVE ADVISORS, L.P.CYTOKINETICS INC +1
• DALAL YOGEN KCYTOKINETICS INC +1
• EMA PARTNERS FUND 2000, L.P.CYTOKINETICS INC +1
• EMA PRIVATE EQUITY FUND 2000, L.P.CYTOKINETICS INC +1
• FONG KEVIN ACYTOKINETICS INC +1
• HEIDRICH A GRANT IIICYTOKINETICS INC +1
• HEMISPHERE PRIVATE EQUITY PARTNERS CHARITABLE TRUSTCYTOKINETICS INC +1
• HEMISPHERE PRIVATE EQUITY PARTNERS, LTD.CYTOKINETICS INC +1
• MAYFIELD IXCYTOKINETICS INC +1
• MAYFIELD IX MANAGEMENT LLCCYTOKINETICS INC +1
• MYERS FRANK G JRCYTOKINETICS INC +1
• UNGER WILLIAM DCYTOKINETICS INC +1
• ADELMAN DANIEL C MDViracta Therapeutics, Inc.
• Aisling Capital IV, LPViracta Therapeutics, Inc.
• Aisling Capital Partners IV LLCViracta Therapeutics, Inc.
• Aisling Capital Partners IV, LPViracta Therapeutics, Inc.
• ALTA BIOPHARMA MANAGEMENT III LLCViracta Therapeutics, Inc.
• ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KGViracta Therapeutics, Inc.
• ALTA BIOPHARMA PARTNERS III LPViracta Therapeutics, Inc.
• ALTA EMBARCADERO BIOPHARMA PARTNERS III LLCViracta Therapeutics, Inc.
• aMoon 2 Fund Limited PartnershipViracta Therapeutics, Inc.
• BARBARI SHARON SURREYCYTOKINETICS INC
• Barlow Jane FViracta Therapeutics, Inc.
• BARRETT M JAMESViracta Therapeutics, Inc.
• BARRIS PETER JViracta Therapeutics, Inc.
• BASKETT FORESTViracta Therapeutics, Inc.
• Bay City Capital Fund V Co-Investment Fund LPViracta Therapeutics, Inc.